Julianne Bruno, Chief Operating Officer at CRISPR Therapeutics AG (CRSP), sold 3,428 shares at $41.23 ($141K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Open-market sale of $141k CRSP by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.23 | 1,714 | $71K | 50.0% |
| 2 | $41.23 | 1,714 | $71K | 50.0% |
| Total | $41.23 avg | 3,428 | $141K | 100% |
| Filing → |
| CRSP | SELL | 2024-06-24 | $378K | — | Filing → |